SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
Clinical trials for SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION trials appear
Sign up with your email to follow new studies for SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New PET tracer could spot deadly lung disease years earlier
Diagnosis Recruiting nowThis early-phase study tests whether a special PET scan tracer, 18F-fluoroglutamine, can detect pulmonary arterial hypertension (PAH) earlier and more accurately. PAH is a serious disease of the lung's blood vessels that often goes undiagnosed for years. The study will scan 71 ad…
Matched conditions: SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
Phase: EARLY_PHASE1 • Sponsor: Stephen Y. Chan • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Scientists probe hidden links between hormones and lung disease
Knowledge-focused Recruiting nowThis study looks at how hormones and metabolism are involved in pulmonary arterial hypertension (PAH), a serious lung condition. Researchers will measure sex hormone levels, insulin resistance, and test two potential treatments—metformin and ACE-2—in small groups. The goal is to …
Matched conditions: SCLERODERMA ASSOCIATED PULMONARY ARTERIAL HYPERTENSION
Sponsor: Vanderbilt University Medical Center • Aim: Knowledge-focused
Last updated Jun 26, 2026 18:37 UTC